Judge Invalidates Reissue Patent For Pfizer's Celebrex
A Virginia federal judge on Wednesday invalidated a key Pfizer Inc. reissue patent covering methods for administering its blockbuster arthritis drug Celebrex, a ruling exposing the company to competition from generics...To view the full article, register now.
Already a subscriber? Click here to view full article